| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,821,430 | 3,924,475 | 4,138,789 | 3,478,999 | 1,938,288 |
| Cost of Revenue
|
-2,370,560 | -2,416,869 | -2,416,827 | -2,040,833 | -1,078,571 |
|
Gross Profit
|
1,450,871 | 1,507,606 | 1,721,962 | 1,438,166 | 859,717 |
| Selling, General and Administrative Expenses
|
-- | -- | -- | -1,132,801 | -823,624 |
|
Research and Development Expenses
|
-- | -- | -- | -38,402 | -37,309 |
| Depreciation, Amortization and Depletion
|
-- | -- | -- | -66,464 | 0 |
| Other Income/Expense, Operating
|
-- | -- | -- | -128,934 | -82,885 |
|
Operating Income/Expenses
|
-1,684,108 | -1,708,723 | -1,625,464 | -1,366,599 | -943,818 |
|
Total Operating Profit/Loss
|
-233,237 | -201,117 | 96,498 | 71,567 | -84,101 |
| Total Net Finance Income/Expense
|
-8,830 | -4,853 | -1,285 | -4,058 | 855 |
| Net Investment Income
|
7,014 | 6,004 | -17,477 | 56,261 | -23,292 |
| Irregular Income/Expenses
|
-212,950 | -209,980 | 42,800 | 4,781 | -1,851 |
|
Other Income/Expense, Non-Operating
|
-22,140 | -23,370 | 0 | -- | -- |
|
Non-Operating Income/Expenses, Total
|
-236,906 | -232,199 | 24,038 | 56,984 | -24,288 |
|
Pretax Income
|
-470,144 | -433,316 | 120,537 | 128,554 | -108,390 |
| Provision for Income Tax
|
-72,769 | -85,386 | -29,453 | -95,654 | -39,789 |
|
Net Income from Continuing Operations
|
-542,913 | -518,702 | 91,084 | 32,900 | -148,179 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-542,913 | -518,702 | 91,084 | 32,900 | -148,179 |
|
Net Income after Non-Controlling/Minority Interests
|
-542,913 | -518,702 | 91,084 | 32,900 | -148,179 |
|
Net Income Available to Common Stockholders
|
-542,913 | -518,702 | 91,084 | 32,900 | -148,179 |
|
Diluted Net Income Available to Common Stockholders
|
-542,913 | -518,702 | 91,084 | 32,900 | -148,179 |
| Basic EPS
|
-51.90 | -49.59 | 8.71 | 3.15 | -14.17 |
| Diluted EPS
|
-51.91 | -49.59 | 8.71 | 3.14 | -14.17 |
|
Basic Weighted Average Shares Outstanding
|
10,458.88 | 10,458.88 | 10,458.88 | 10,444.44 | 10,457.23 |
|
Diluted Weighted Average Shares Outstanding
|
10,458.88 | 10,458.88 | 10,458.88 | 10,462.52 | 10,457.23 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-461,314 | -428,463 | 121,822 | 132,612 | -109,245 |
|
EBITDA
|
-256,644 | -256,644 | 244,590 | 227,027 | -66,802 |
|
Normalized EBITDA
|
-45,239 | -45,239 | 219,159 | 180,641 | -33,838 |
|
Normalized Income
|
-379,367.40 | -213,688 | 92,889 | 87,649 | -76,179 |
3/31/2023 - 11/13/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade